[{"id":"b480d7b1-b74a-44f5-b489-6721131f675a","acronym":"","url":"https://clinicaltrials.gov/study/NCT05909527","created_at":"2023-06-18T17:07:54.188Z","updated_at":"2024-07-02T16:35:42.049Z","phase":"Phase 1/2","brief_title":"A Clinical Study of CAR-T Treating Relapsed or Refractory T Cell Lymphoblastic Acute Leukemia/ Lymphoma","source_id_and_acronym":"NCT05909527","lead_sponsor":"Guangzhou Bio-gene Technology Co., Ltd","biomarkers":" CD7","pipe":"","alterations":" ","tags":["CD7"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD7 CAR-T"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 05/01/2023","start_date":" 05/01/2023","primary_txt":" Primary completion: 08/01/2028","primary_completion_date":" 08/01/2028","study_txt":" Completion: 08/01/2028","study_completion_date":" 08/01/2028","last_update_posted":"2023-07-25"}]